1 Pepys MB . Studies in vivo of cobra venom factor and murine C3.Immunology1975; 2: 369 – 377 .
2.
2 Kemper CAtkinson JP . T-cell regulation: with compliments from innate immunity.Nat Rev Immunol2007; 7: 9 – 18 .
3.
3 Nauta AJDaha MRVan Kooten CRoos A . Recognition and clearance of apoptotic cells: a role for complement and pentraxins.Trends Immunol2003; 24: 148 – 154 .
4.
4 Trouw LASeelen MADuijs JM . Activation of the lectin pathway in murine lupus nephritis.Mol Immunol2005; 42: 731 – 740 .
5.
5 Selander BMårtensson UWeintraub A . Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2.J Clin Invest2006; 116: 1425 – 1434 .
6.
6 Spitzer DMitchell LMAtkinson JPHourcade DE . Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly.J Immol2007; 179: 2600 – 2608 .
7.
7 Seelen MADaha MR . The role of complement in autoimmune renal disease.Autoimmunity2006; 39: 411 – 415 .
8.
8 Trouw LADaha MR . Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis.Expert Opin Biol Ther2005; 5: 243 – 251 .
9.
9 Trouw LAGroeneveld TWSeelen MA . Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.J Clin Invest2004; 114: 679 – 688 .
10.
10 Siegert CEDaha MRWestedt MLvan de Voort EABreedveld FC . IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.J Rheumatol1991; 18: 230 – 234 .
11.
11 Trendelenburg MLopez-Trascasa MPotlukova E . High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.Nephrol Dial Transplant2006; 21: 3115 – 3121 . Epub 2006 Jul 28
12.
12 Agnello VWinchester RJKunkel HG . Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.Immunology1970; 19: 909 – 919 .
